Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00934
|
|||||
| Drug Name |
Indatraline
|
|||||
| Synonyms |
(+)-Indatraline; (+-)-trans-3-(3,4-Dichlorophenyl)-N-methyl-1-indanamine; (-)-trans-3-(3,4-dichlorophenyl)-n-methyl-1-indanamine; 3-(3,4-Dichlorophenyl)-N-methyl-1-indanamine hcl; 86939-10-8; 97229-15-7; AC1L2Q22; AC1Q3O5Q; API0009127; BDBM50095618; CCG-204769; CHEMBL341898; DTXSID4043981; Indatraline; Indatraline [INN]; Indatralinum; Lopac-I-119; Lopac0_000684; Lu 19005; Lu-19-005; NCGC00015532-01; NCGC00025223-02; NCGC00025223-03; NCGC00025223-04; PDSP1_001502; PDSP2_001486; SCHEMBL9252640; UNII-4U40Y96J1Z c; ZINC3872906
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C16H15Cl2N
|
|||||
| Canonical SMILES |
CNC1CC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
|
|||||
| InChI |
InChI=1S/C16H15Cl2N/c1-19-16-9-13(11-4-2-3-5-12(11)16)10-6-7-14(17)15(18)8-10/h2-8,13,16,19H,9H2,1H3/t13-,16+/m0/s1
|
|||||
| InChIKey |
SVFXPTLYMIXFRX-XJKSGUPXSA-N
|
|||||
| CAS Number |
CAS 86939-10-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 292.2 | Topological Polar Surface Area | 12 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 1 | |||
| XLogP |
4.4
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.